0001259942-17-000004.txt : 20171221 0001259942-17-000004.hdr.sgml : 20171221 20171221163926 ACCESSION NUMBER: 0001259942-17-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171221 DATE AS OF CHANGE: 20171221 EFFECTIVENESS DATE: 20171221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BELLUS Health Inc. CENTRAL INDEX KEY: 0001259942 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-301454 FILM NUMBER: 171269890 BUSINESS ADDRESS: STREET 1: 275 ARMAND-FRAPPIER BLVD. CITY: LAVAL STATE: A8 ZIP: H7V 4A7 BUSINESS PHONE: 450-680-4500 MAIL ADDRESS: STREET 1: 275 ARMAND-FRAPPIER BLVD. CITY: LAVAL STATE: A8 ZIP: H7V 4A7 FORMER COMPANY: FORMER CONFORMED NAME: NEUROCHEM INC DATE OF NAME CHANGE: 20030814 D 1 primary_doc.xml X0708 D LIVE 0001259942 BELLUS Health Inc. 275 ARMAND-FRAPPIER BLVD. LAVAL A8 QUEBEC, CANADA H7V 4A7 450-680-4500 CANADA (FEDERAL LEVEL) NEUROCHEM INC Corporation true Roberto Bellini 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Executive Officer Director President and Chief Executive Officer Denis Garceau 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Executive Officer Senior Vice President, Drug Development Francois Desjardins 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Executive Officer Vice President, Finance Tony Matzouranis 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Executive Officer Vice President, Business Development Francesco Bellini 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Director Youssef L. Bennani 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Director Franklin Berger 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Director Clarissa Desjardins 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Director Pierre Larochelle 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Director Joseph Rus 275 Armand-Frappier Blvd. Laval A8 QUEBEC, CANADA H7V 4A7 Director Pharmaceuticals Decline to Disclose 06b false 2017-12-12 false true false 0 9608732 9608732 0 CONVERTED FROM CANADIAN DOLLARS USING THE BANK OF CANADA EXCHANGE RATE ON DECEMBER 12, 2017. false 8 0 0 0 Primarily to fund research and development activities, general and administrative expenses, working capital needs and other general corporate purposes. false BELLUS Health Inc. /s/ Francois Desjardins Francois Desjardins Vice President, Finance 2017-12-21